---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009411"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2024-03-08T23:59:59+00:00"
generated_at: "2026-06-05T00:32:51.041446+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PAVmed receives Nasdaq delisting notice for MVLS below $35M minimum

## Summary
- Nasdaq notified PAVmed on March 7, 2024 that MVLS was below $35M for 30 consecutive days through March 6.
- Company has 180 calendar days (until Sept 3, 2024) to regain compliance; MVLS must close at $35M+ for 10 consecutive days.
- If compliance not regained by deadline, Nasdaq will issue written notification that securities are subject to delisting.
- The notice does not immediately affect trading; PAVM and PAVMZ continue uninterrupted on Nasdaq Capital Market.
- PAVmed intends to evaluate all available options to regain compliance with Nasdaq listing standards.

## SEC filing metadata
- accession: 0001493152-24-009411
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2024-03-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315224009411/0001493152-24-009411-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315224009411/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009411
- JSON: https://secwatch.observer/filing/0001493152-24-009411.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009411.txt

## Key facts
- Listing & Compliance Notices
  PAVmed Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: March 7, 2024, PAVmed Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) stating that, for the last 30 consecutive business days (through March 6, 2024), the market value of the Company’s listed securities (“ MVLS ”) had been below the minimum of $35 million required for continued inclusion on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2). The notification letter stated that the Company would be afforded 180 calendar days (until September 3, 2024) to regain compliance. In order to regain compliance, the C
  evidence_url: https://www.sec.gov/Archives/edgar/data/1624326/000149315224009411/0001493152-24-009411-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.